111 related articles for article (PubMed ID: 30317880)
1. Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels.
Okamura S; Osaki T; Nishimura K; Ohsaki H; Shintani M; Matsuoka H; Maeda K; Shiogama K; Itoh T; Kamoshida S
Biotech Histochem; 2019 Jan; 94(1):60-64. PubMed ID: 30317880
[TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.
Brockenbrough JS; Morihara JK; Hawes SE; Stern JE; Rasey JS; Wiens LW; Feng Q; Vesselle H
J Histochem Cytochem; 2009 Nov; 57(11):1087-97. PubMed ID: 19654105
[TBL] [Abstract][Full Text] [Related]
3. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.
Mao Y; Wu J; Skog S; Eriksson S; Zhao Y; Zhou J; He Q
Oncol Rep; 2005 May; 13(5):837-46. PubMed ID: 15809747
[TBL] [Abstract][Full Text] [Related]
5. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
6. Comparative Study of Correlation between Angiogenesis Markers (CD31) and Ki67 Marker with Behavior of Aggressive and Nonaggressive Central Giant Cell Granuloma with Immunohistochemistry Technique.
Razavi SM; Yahyaabadi R
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2279-2283. PubMed ID: 30139237
[TBL] [Abstract][Full Text] [Related]
7. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways.
Wei Q; Liu H; Zhou H; Zhang D; Zhang Z; Zhou Q
BMC Cancer; 2015 Mar; 15():159. PubMed ID: 25881156
[TBL] [Abstract][Full Text] [Related]
9. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Rausch S; Hennenlotter J; Teepe K; Kuehs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
Urol Oncol; 2015 Oct; 33(10):426.e21-9. PubMed ID: 26231311
[TBL] [Abstract][Full Text] [Related]
10. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
11. Time course of enhanced activity of deoxycytidine kinase and thymidine kinase 1 and 2 in cultured human squamous lung carcinoma cells, SW-1573, induced by gamma-irradiation.
Haveman J; Sigmond J; van Bree C; Franken NA; Koedooder C; Peters GJ
Oncol Rep; 2006 Oct; 16(4):901-5. PubMed ID: 16969512
[TBL] [Abstract][Full Text] [Related]
12. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
Schlüter A; Weller P; Kanaan O; Nel I; Heusgen L; Höing B; Haßkamp P; Zander S; Mandapathil M; Dominas N; Arnolds J; Stuck BA; Lang S; Bankfalvi A; Brandau S
BMC Cancer; 2018 Mar; 18(1):272. PubMed ID: 29523110
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Bösmüller H; Pfefferle V; Bittar Z; Scheble V; Horger M; Sipos B; Fend F
Pathol Res Pract; 2018 Aug; 214(8):1136-1141. PubMed ID: 29935812
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
Canosa S; Moggio A; Brossa A; Pittatore G; Marchino GL; Leoncini S; Benedetto C; Revelli A; Bussolati B
Mol Hum Reprod; 2017 Mar; 23(3):187-198. PubMed ID: 28158750
[TBL] [Abstract][Full Text] [Related]
15. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
[TBL] [Abstract][Full Text] [Related]
16. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays.
Gasparri F; Wang N; Skog S; Galvani A; Eriksson S
Eur J Cell Biol; 2009 Dec; 88(12):779-85. PubMed ID: 19726104
[TBL] [Abstract][Full Text] [Related]
18. Normal and neoplastic cells of brown adipose tissue express the adhesion molecule CD31.
Rosso R; Lucioni M
Arch Pathol Lab Med; 2006 Apr; 130(4):480-2. PubMed ID: 16594742
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase 1 through the ages: a comprehensive review.
Bitter EE; Townsend MH; Erickson R; Allen C; O'Neill KL
Cell Biosci; 2020 Nov; 10(1):138. PubMed ID: 33292474
[TBL] [Abstract][Full Text] [Related]
20. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
Lee SB; Oh HK; Kim HK; Joe YA
Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
